Effects of Constitutive β-Catenin Activation on Vertebral Bone Growth and Remodeling at Different Postnatal Stages in Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Jia, Min ^a   Chen, Sixu ^a   Zhang, Bo ^a   Liang, Huaping ^a   Feng, Jianquan ^b   Zong, Zhaowen ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MASS; BONE REMODELING; CONSTITUTIVE ACTIVATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GROWTH INHIBITION; GROWTH PLATE; IMMATURITY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PERINATAL PERIOD; PROTEIN PROCESSING; PROTEIN STABILITY; SHORT STATURE; VERTEBRA; VERTEBRA BODY;

ANIMALS; BETA CATENIN; BONE DEVELOPMENT; CELL DIFFERENTIATION; FEMALE; GROWTH PLATE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; SIGNAL TRANSDUCTION; VERTEBRATES;

EID: 84884191372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074093     Document Type: Article

References (36)

1. Clevers H, Nusse R, (2012) Wnt/β-catenin signaling and disease. Cell 149: 1192-1205. doi:10.1016/j.cell.2012.05.012. PubMed: 22682243.
2. Huang S, Zhu X, Liu Y, Tao Y, Feng G, et al. (2012) Wls is expressed in the epidermis and regulates embryonic hair follicle induction in mice. PLOS ONE 27: e45904. doi:10.1371/journal.pone.0045904. PubMed: 23029304.
3. Zhang Z, Wlodarczyk BJ, Niederreither K, Venugopalan S, Florez S, et al. (2011) Fuz regulates craniofacial development through tissue specific responses to signaling factors. PLOS ONE 6: e24608. doi:10.1371/journal.pone.0024608. PubMed: 21935430.
4. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, et al. (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132: 1995-2005. doi:10.1242/dev.01786. PubMed: 15790973.
5. Krishnan V, Bryant HU, Macdougald OA, (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209. doi:10.1172/JCI28551. PubMed: 16670761.
6. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, et al. (2005) Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 280: 21162-21168. doi:10.1074/jbc.M501900200. PubMed: 15802266.
7. Gong Y, Bourhis E, Chiu C, Stawicki S, DeAlmeida VI, et al. (2010) Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies. PLOS ONE 5: e12682. doi:10.1371/journal.pone.0012682. PubMed: 20856934.
8. Kocemba KA, Groen RW, van Andel H, Kersten MJ, Mahtouk K, et al. (2012) Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma. PLOS ONE 7: e30359. doi:10.1371/journal.pone.0030359. PubMed: 22363428.
9. Williams BO, Insogna KL, (2009) Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 24: 171-178. doi:10.1359/jbmr.081235. PubMed: 19072724.
10. Joeng KS, Schumacher CA, Zylstra-Diegel CR, Long F, Williams BO, (2011) Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. Dev Biol 359: 222-229. PubMed: 21924256.
11. Kubota T, Michigami T, Sakaguchi N, Kokubu C, Suzuki A, et al. (2008) Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd. J Bone Miner Res 23: 1661-1671. doi:10.1359/jbmr.080512. PubMed: 18505367.
12. Dela Cruz F, Terry M, Matushansky I, (2012) A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects. Differentiation 83: 220-230. doi:10.1016/j.diff.2012.01.001. PubMed: 22406973.
13. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, et al. (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23: 860-869. doi:10.1359/jbmr.080216. PubMed: 18269310.
14. Hoeppner LH, Secreto FJ, Westendorf JJ, (2009) Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets 13: 485-496. doi:10.1517/14728220902841961. PubMed: 19335070.
15. Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, et al. (2006) Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21: 910-920. doi:10.1359/jbmr.060316. PubMed: 16753022.
16. Hoeppner LH, Secreto FJ, Razidlo DF, Whitney TJ, Westendorf JJ, (2011) Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. J Biol Chem 286: 10950-10959. doi:10.1074/jbc.M110.165100. PubMed: 21270130.
17. Padhi D, Jang G, Stouch B, Fang L, Posvar E, (2011) Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26: 19-26. doi:10.1002/jbmr.173. PubMed: 20593411.
18. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, et al. (2010) Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 11: 161-171. doi:10.1016/j.cmet.2009.12.007. PubMed: 20142103.
19. Cawthorn WP, Bree AJ, Yao Y, Du B, Hemati N, et al. (2012) Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone 50: 477-489. doi:10.1016/j.bone.2011.08.010. PubMed: 21872687.
20. Clément-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssière B, et al. (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci U S A 102: 17406-17411. doi:10.1073/pnas.0505259102. PubMed: 16293698.
21. Verkaar F, van der Stelt M, Blankesteijn WM, van der Doelen AA, Zaman GJ, (2011) Discovery of novel small molecule activators of β-catenin signaling. PLOS ONE 6: e19185. doi:10.1371/journal.pone.0019185. PubMed: 21559429.
22. Marsell R, Sisask G, Nilsson Y, Sundgren-Andersson AK, Andersson U, et al. (2012) GSK-3 inhibition by an orally active small molecule increases bone mass in rats. Bone 50: 619-627. doi:10.1016/j.bone.2011.11.007. PubMed: 22142634.
23. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8: 751-764. doi:10.1016/j.devcel.2005.02.017. PubMed: 15866165.
24. Boland GM, Perkins G, Hall DJ, Tuan RS, (2004) Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93: 1210-1230. doi:10.1002/jcb.20284. PubMed: 15486964.
25. Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, et al. (2007) Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLOS Med 4: e249. doi:10.1371/journal.pmed.0040249. PubMed: 17676991.
26. Heo JS, Lee SY, Lee JC, (2010) Wnt/β-catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts. Mol Cells 30: 449-454. doi:10.1007/s10059-010-0139-3. PubMed: 20848229.
27. Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, et al. (2010) Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 25: 200-210. doi:10.1359/jbmr.090806. PubMed: 19874086.
28. Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, et al. (2008) Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res 23: 2007-2017. doi:10.1359/jbmr.080809. PubMed: 18684091.
29. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, et al. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38: 1310-1315. doi:10.1038/ng1905. PubMed: 17033621.
30. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, et al. (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25: 1468-1486. PubMed: 20533309.
31. Zong ZW, Cheng TM, Su YP, Ran XZ, Shen Y, et al. (2008) Recruitment of transplanted dermal multipotent stem cells to sites of injury in rats with combined radiation and wound injury by interaction of SDF-1 and CXCR4. Radiat Res 170: 444-450. doi:10.1667/RR0744.1. PubMed: 19024651.
32. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, et al. (2009) Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res 24: 1055-1065. doi:10.1359/jbmr.081248. PubMed: 19113927.
33. Baek WY, de Crombrugghe B, Kim JE, (2010) Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone 46: 920-928. doi:10.1016/j.bone.2009.12.007. PubMed: 20026264.
34. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, et al. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280: 33132-33140. doi:10.1074/jbc.M500608200. PubMed: 16043491.
35. Day TF, Guo X, Garrett-Beal L, Yang Y, (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739-750. doi:10.1016/j.devcel.2005.03.016. PubMed: 15866164.
36. Chen J, Long F, (2013) β-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice. J Bone Miner Res 28: 1160-1169. doi:10.1002/jbmr.1834. PubMed: 23188722.